Home - National Drug Authority

NDA STRENGTHENS IP CAPACITY AHEAD OF TISC LAUNCH

NDA STRENGTHENS IP CAPACITY AHEAD OF TISC
LAUNCH

The National Drug Authority (NDA) held a Research Roundtable Discussion on Thursday, 26th February 2026, titled "Protecting innovation in traditional and complementary medicines: The role of patent databases in regulatory practice".

ISO 9001:2015 CERTIFICATION

ISO 9001:2015 CERTIFICATION

National Drug Authority is ISO 9001:2015 Certified

ISO/IEC 17025:2017 ACCREDITATION

View full certificate

ISO/IEC 17025:2017 ACCREDITATION

National Drug Quality Control Laboratory is ISO/IEC 17025:2017 Accredited

ONLINE SERVICES

IRMIS CLIENT

RCALLS

drug register

DRUG SHOPS

clinical 1 trials

LICENSED OUTLETS

LICENSED STATS

GMP FACILITIES

REGISTRATION STATISTICS

DRUG PROMOTION

MEDICAL DEVICES

PRODUCT SAFETY

PRODUCT ASSESSMENT
& REGISTRATION

INSPECTORATE & ENFORCEMENT
SERVICES

LABORATORY SERVICES

MARKET COMPLAINT REQUEST FORM - PART 1

VETERINARY DRUGS

vet12

LATEST NEWS

NDA Strengthens IP Capacity Ahead of TISC Launch

NDA at EKisaakate 2026

January 9, 2026

NDA approves Lenacapavir, a twice-yearly dose PrEP manufactured by Gilead

January 5, 2026

e-report4

imageedit_23_2048989001

ELIBRARY copy